ADSTILADRIN DIN 02566680
Health Canada record
| Active ingredient(s) | NADOFARAGENE FIRADENOVEC 300000000000 VP |
|---|---|
| Dosage form | Suspension |
| Route | Intravesical |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | L01XL10 NADOFARAGENE FIRADENOVEC |
| Original market date | |
| Current status date | 16-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37129 | 2026-03-16 | New Drug Submission (NDS) |